rs886061616
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_138694.4(PKHD1):c.8068T>C(p.Trp2690Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000031 in 1,613,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W2690G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_138694.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PKHD1 | NM_138694.4 | c.8068T>C | p.Trp2690Arg | missense_variant | 50/67 | ENST00000371117.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PKHD1 | ENST00000371117.8 | c.8068T>C | p.Trp2690Arg | missense_variant | 50/67 | 1 | NM_138694.4 | P2 | |
PKHD1 | ENST00000340994.4 | c.8068T>C | p.Trp2690Arg | missense_variant | 50/61 | 5 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.0000131 AC: 2AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251196Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135740
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461754Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727192
GnomAD4 genome ? AF: 0.0000131 AC: 2AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74378
ClinVar
Submissions by phenotype
Autosomal recessive polycystic kidney disease Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Nov 13, 2023 | This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 2690 of the PKHD1 protein (p.Trp2690Arg). This variant is present in population databases (no rsID available, gnomAD 0.007%). This missense change has been observed in individual(s) with autosomal recessive polycystic kidney disease (PMID: 14971004, 15698423, 19021639, 20413436). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 357427). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PKHD1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Feb 20, 2018 | The PKHD1 c.8068T>C (p.Trp2690Arg) missense variant has been reported in a compound heterozygous state in four individuals, including a sibling pair, diagnosed with autosomal recessive polycystic kidney disease (Sgro et al. 2004; Bergmann et al. 2005; Michel-Calemard et al. 2009; Gunay-Aygun et al. 2010). The variant was absent from at least 604 control chromosomes and is reported at a frequency of 0.000027 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the evidence, the p.Trp2690Arg variant is classified as likely pathogenic for autosomal recessive polycystic kidney disease. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 06, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Counsyl | Aug 29, 2017 | - - |
Polycystic kidney disease 4 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jun 22, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 12, 2022 | - - |
PKHD1-related condition Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 01, 2024 | The PKHD1 c.8068T>C variant is predicted to result in the amino acid substitution p.Trp2690Arg. This variant has been reported with different pathogenic PKHD1 variants in individuals with autosomal recessive polycystic kidney disease (ARPKD) (Bergmann et al. 2005. PubMed ID: 15698423; Gunay-Argan et al. 2009. PubMed ID: 19914852; Sgro et al. 2004. PubMed ID: 14971004). Of note, at PreventionGenetics, we have also found this variant with another pathogenic PKHD1 variant in a patient tested for polycystic kidney disease. This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 08, 2017 | The W2690R variant in the PKHD1 gene has been reported previously in the heterozygous state with another disease-causing variant in patients with ARPKD and Caroli disease (Sgro et al, 2004; Michel-Calemard et al., 2009; Gunay-Aygun et al., 2010; Gunay-Aygun et al., 2011). The W2690R variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The W2690R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret W2690R as a likely pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at